Riskpilot← Back to searchSign inGet full accessHolten Institute AB
ABActiveOrg 5565993044Grantunet 5Physiotherapy activities · NACE 8695Est. 20001 employees
Revenue 2025
SEK 1,5M
0% vs 2024
EBITDA margin
19.9%
+15% vs 2024
Equity ratio
73.9%
Financial strength
Net profit 2025
SEK 273K
+19% vs 2024
| Revenue | SEK 1,5M | +0% |
| EBITDA | SEK 308K | +15% |
| Net profit | SEK 273K | +19% |
| Total assets | SEK 576K | +6% |
| Equity | SEK 426K | +13% |
| Employees | 1 | — |
Legal name
Holten Institute AB
Org number
5565993044
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
20 oktober 2000
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva verksamhet omfattande utveckling och an- ordnande av kursverksamhet främst inom medicinsk träningsterapi, bedriva försäljning av varor med koppling till verksamheten samt bedriva sjukgymnastisk patientbehandling ävensom idka därmed förenlig verksamhet.
Address
Grantunet 5
Email
tom.torstensen@holteninstitute.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 265 | 1 589 | 1 642 | 1 553 | 1 547 |
| Staff expenses | — | −978 | −962 | −751 | −622 |
| EBITDA | −8 | 63 | 66 | 267 | 308 |
| Depreciation & amort. | −157 | — | — | — | — |
| EBIT | −165 | 63 | 66 | 267 | 308 |
| Net financials | −6 | −4 | −4 | −3 | 44 |
| Profit before tax | −172 | 60 | 62 | 265 | 353 |
| Tax | −0 | — | — | −36 | −80 |
| Net profit | −172 | 60 | 62 | 229 | 273 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 229 | 312 | 386 | 543 | 576 |
| Equity | 107 | 166 | 229 | 377 | 426 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 122 | 146 | 158 | 166 | 150 |
| Total debt | 122 | 146 | 158 | 166 | 150 |
EBITDA margin
19.9%
This company
15.8%
Market median
+26% vs market
20212025
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
20212025
Return on equity
64.2%
This company
18.4%
Market median
+249% vs market
20212025
Net profit margin
17.7%
This company
8.1%
Market median
+119% vs market
20212025
Asset turnover
2.69×
This company
1.12×
Market median
+140% vs market
20212025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JR Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Holten Institute AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Roland Brehme | Audit | 0 companies |
| Tom Arild Torstensen | Board of Directors | 0 companies |
| Anna Heléne Torstensen | Deputy Board Member | 0 companies |